Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

How ready are medics for a chemical attack? new study aims to find out

NCT ID NCT05026645

Knowledge-focused Sponsor: St. Justine's Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well medical teams follow safety guidelines when treating people hurt in a chemical, biological, or nuclear attack. Researchers will track 1,000 patients to see if care is given without delay and if contamination is controlled during rescue. The goal is to improve emergency response and protect both patients and healthcare workers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2020

Expected to finish

Dec 2036

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Population is being studied includes any individual who was affected by CBRNE attacks and needed an intervention of the healthcare system.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: i. a CBRNE attack caused at least one casualty who required the assistance of the participating health care system (e.g.: physicians, nurses, paramedics and other health-care specialists of a medical facility) during a medical extraction from the incident site until admission to a medical facility; ii. Patients are eligible if they were exposed to the CBRNE attack; iii. Medical information concerning the CBRNE exposures, even if partial, is accessible to health care professionals for the purposes of filling out the online case report form (eCRF); iv. Participants must be able to complete the online case report form in English; and v. The approval of an Ethics Review Board is obtained by each medical centre participant. Exclusion Criteria: A negative response to any of the inclusion criteria results in an exclusion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute respiratory distress syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute respiratory distress syndrome adult acute respiratory distress syndrome poisoning Pulmonary Atelectasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute respiratory distress syndrome Chemical injury Chemicals; intoxication Distress respiratory syndrome Medical emergencies

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    15 sites in 6 countries. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Biomedical Telematics Laboratory Platform of the Quebec Respiratory Health Research Network

    Sherbrooke, Quebec, J1K 2R1, Canada

  • CBRNE World Journal

    Winchester, SO23 8UT, United Kingdom

  • Centre for Defence and Security Studies, University of Manitoba

    Winnipeg, Manitoba, R3T 2N2, Canada

  • Department of Critical care, Miyagi Children's Hospital

    Tokyo, Japan

  • Department of Disaster Medical Management, The University of Tokyo Hospital

    Tokyo, Japan

  • Director, Unconventional Weapons & Technology Division, National Consortium for the Study of Terrorism and Responses to Terrorism University of Maryland

    College Park, Maryland, 20740, United States

  • Medical Intelligence CBRNE Inc.

    Québec, Quebec, G1V0C8, Canada

  • Research Center of the CHU St-Justine, University of Montreal

    Montreal, Quebec, H3T 1C5, Canada

  • Research Centre, Quebec Heart and Lung Institute, Laval University

    Québec, Quebec, G1V 4G5, Canada

  • Royal Canadian Medical Corps

    Ottawa, Ontario, K1A0K2, Canada

  • Sorbonne University

    Paris, Île-de-France Region, France

  • Surrey and Sussex Healthcare NHS Trust

    Surrey Quays, Redhill, RH1 5RH, United Kingdom

  • Tokyo Women's Medical University, Department of Intensive Care Medicine

    Tokyo, Shinjuku-ku, Japan

  • University of Finance and Administration Department of Criminology and Forensic Disciplines

    Prague, Prague, 10100, Czechia

  • École de Technologie Supérieure Université du Québec

    Montreal, Quebec, H3C 1K3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.